Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001079973-25-001813

Director sold 50,000 shares at $4.00 ($200,000)

From the SEC's structured data for this filing

Trades in this filing

Pacala Mark L · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-18 Sale : show line 1 in the form −2,160 $4.00 $8,640 222,811 D
2025-11-18 Sale : show line 2 in the form −1,210 $4.00 $4,840 221,601 D
2025-11-18 Sale : show line 3 in the form −46,630 $4.00 $186,520 174,971 D
Open-market sales · 50,000 sh · avg $4.00 · $200,000
Loading xslF345X05/ownership.xml…